Uncategorized
Ocular Therapeutix™ to Present at the 2019 Cantor Global Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Donald Notman, Chief Financial Officer of Ocular Therapeutix, will give a company presentation on Friday, October 4th at 1:45 p.m. EDT at the 2019 Cantor Global Healthcare Conference at the InterContinental New York Barclay in New York City. In additi